HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wheatley, C M Articles by Sale, M M Search for Related Content PubMed PubMed Citation Articles by Wheatley, C M Articles by Sale, M M

Retinopathy of prematurity: recent advances in our understanding

¹ Discipline of Biochemistry, University of Tasmania, Hobart, Tasmania, Australia
² Menzies Centre for Population Health Research, University of Tasmania, Hobart, Tasmania, Australia
³ Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia

Correspondence to:
Correspondence to:
Michéle Sale, PhD, Menzies Centre for Population Health Research, University of Tasmania, GPO Box 252-23, Hobart, Tasmania 7001, Australia;
Michele.Sale{at}utas.edu.au

ABSTRACT
Retinopathy of prematurity (ROP) has been recognised as an important cause of childhood visual impairment and blindness since the 1940s when improved facilities and treatment increased the survival rate of premature infants. Although its incidence and severity have been decreasing in developed countries over the past two decades, both are increasing in developing nations. ROP is consequently targeted as an important but avoidable disease. This review provides an updated summary and discussion of much of the work that has been produced through population, animal, cell culture, and genetic research. The authors examine the prevalence, risk factors, and possible causes of the disease with a particular focus on genetic studies. They conclude that while significant reductions in the disease have occurred in developed countries, further research is required to fully understand and prevent the disease. In the meantime, development and implementation of appropriate screening and treatment strategies will be critical in reducing blindness in developing countries.

Keywords: retinopathy of prematurity; children

This article has been cited by other articles:

				E M Lad, T C Nguyen, J M Morton, and D M Moshfeghi Retinopathy of prematurity in the United States Br. J. Ophthalmol., March 1, 2008; 92(3): 320 - 325. [Abstract] [Full Text] [PDF]

				P. van Wijngaarden, H. M. Brereton, D. J. Coster, and K. A. Williams Genetic Influences on Susceptibility to Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1761 - 1766. [Abstract] [Full Text] [PDF]

				M. E. Msall The retina as a window to the brain in vulnerable neonates. Pediatrics, June 1, 2006; 117(6): 2287 - 2289. [Full Text] [PDF]

				E M Boyle, Y Freer, Z Khan-Orakzai, M Watkinson, E Wright, J R Ainsworth, and N McIntosh Sucrose and non-nutritive sucking for the relief of pain in screening for retinopathy of prematurity: a randomised controlled trial Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F166 - F168. [Abstract] [Full Text] [PDF]

				M. Loeliger, J. Duncan, S. Louey, M. Cock, R. Harding, and S. Rees Fetal Growth Restriction Induced by Chronic Placental Insufficiency Has Long-Term Effects on the Retina but Not the Optic Nerve Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3300 - 3308. [Abstract] [Full Text] [PDF]

				V Vedantham and P K Ratnagiri Causes of severe visual impairment and blindness in children in Ethiopia Br. J. Ophthalmol., November 1, 2003; 87(11): 1432 - 1432. [Full Text]